Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

170 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
p53 Pathway dysfunction in primary childhood ependymomas.
Gaspar N, Grill J, Geoerger B, Lellouch-Tubiana A, Michalowski MB, Vassal G. Gaspar N, et al. Pediatr Blood Cancer. 2006 May 1;46(5):604-13. doi: 10.1002/pbc.20532. Pediatr Blood Cancer. 2006. PMID: 16086408
Bone sarcomas: from biology to targeted therapies.
Gaspar N, Di Giannatale A, Geoerger B, Redini F, Corradini N, Enz-Werle N, Tirode F, Marec-Berard P, Gentet JC, Laurence V, Piperno-Neumann S, Oberlin O, Brugieres L. Gaspar N, et al. Sarcoma. 2012;2012:301975. doi: 10.1155/2012/301975. Epub 2012 Nov 27. Sarcoma. 2012. PMID: 23226965 Free PMC article.
Patients in pediatric phase I and early phase II clinical oncology trials at Gustave Roussy: a 13-year center experience.
Bautista F, Di Giannatale A, Dias-Gastellier N, Fahd M, Valteau-Couanet D, Couanet D, Grill J, Brugières L, Dufour C, Gaspar N, Minard-Colin V, Kalifa C, Oberlin O, Patte C, Vassal G, Geoerger B. Bautista F, et al. Among authors: gaspar n. J Pediatr Hematol Oncol. 2015 Mar;37(2):e102-10. doi: 10.1097/MPH.0000000000000237. J Pediatr Hematol Oncol. 2015. PMID: 25171452 Clinical Trial.
Molecular Screening for Cancer Treatment Optimization (MOSCATO-01) in Pediatric Patients: A Single-Institutional Prospective Molecular Stratification Trial.
Harttrampf AC, Lacroix L, Deloger M, Deschamps F, Puget S, Auger N, Vielh P, Varlet P, Balogh Z, Abbou S, Allorant A, Valteau-Couanet D, Sarnacki S, Gamiche-Rolland L, Meurice G, Minard-Colin V, Grill J, Brugieres L, Dufour C, Gaspar N, Michiels S, Vassal G, Soria JC, Geoerger B. Harttrampf AC, et al. Among authors: gaspar n. Clin Cancer Res. 2017 Oct 15;23(20):6101-6112. doi: 10.1158/1078-0432.CCR-17-0381. Epub 2017 Jul 21. Clin Cancer Res. 2017. PMID: 28733441 Clinical Trial.
Establishment and characterization of in vivo orthotopic bioluminescent xenograft models from human osteosarcoma cell lines in Swiss nude and NSG mice.
Marques da Costa ME, Daudigeos-Dubus E, Gomez-Brouchet A, Bawa O, Rouffiac V, Serra M, Scotlandi K, Santos C, Geoerger B, Gaspar N. Marques da Costa ME, et al. Among authors: gaspar n. Cancer Med. 2018 Mar;7(3):665-676. doi: 10.1002/cam4.1346. Epub 2018 Feb 23. Cancer Med. 2018. PMID: 29473324 Free PMC article.
In-Vitro and In-Vivo Establishment and Characterization of Bioluminescent Orthotopic Chemotherapy-Resistant Human Osteosarcoma Models in NSG Mice.
Marques da Costa ME, Marchais A, Gomez-Brouchet A, Job B, Assoun N, Daudigeos-Dubus E, Fromigué O, Santos C, Geoerger B, Gaspar N. Marques da Costa ME, et al. Among authors: gaspar n. Cancers (Basel). 2019 Jul 17;11(7):997. doi: 10.3390/cancers11070997. Cancers (Basel). 2019. PMID: 31319571 Free PMC article.
Immune Infiltrate and Tumor Microenvironment Transcriptional Programs Stratify Pediatric Osteosarcoma into Prognostic Groups at Diagnosis.
Marchais A, Marques da Costa ME, Job B, Abbas R, Drubay D, Piperno-Neumann S, Fromigué O, Gomez-Brouchet A, Redini F, Droit R, Lervat C, Entz-Werle N, Pacquement H, Devoldere C, Cupissol D, Bodet D, Gandemer V, Berger M, Marec-Berard P, Jimenez M, Vassal G, Geoerger B, Brugières L, Gaspar N. Marchais A, et al. Among authors: gaspar n. Cancer Res. 2022 Mar 15;82(6):974-985. doi: 10.1158/0008-5472.CAN-20-4189. Cancer Res. 2022. PMID: 35078815
170 results